Literature DB >> 7808055

Cavitary pulmonary infarct in immunocompromised hosts.

T I Morgenthaler1, J H Ryu, J P Utz.   

Abstract

Pulmonary disease in immunocompromised patients is common, but cavitary lung disease is less common and is usually associated with a fungal or mycobacterial infection. Pulmonary embolism is a noninfectious cause of a cavitary pulmonary process. Pulmonary embolism causes infarction in fewer than 15% of cases, and only about 5% of infarctions cavitate. Herein we describe two cases of cavitary infarcts in immunocompromised patients and review the clinical aspects of pulmonary infarcts and cavitation. Cavitary pulmonary infarction has been reported only rarely in immunocompromised patients. It is a dangerous but treatable pulmonary disease that must be considered in the differential diagnosis of immuno-compromised patients with lung disease.

Entities:  

Mesh:

Year:  1995        PMID: 7808055     DOI: 10.1016/S0025-6196(11)64668-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  A Case Report: Cavitary Infarction Caused by Pulmonary Tumor Thrombotic Microangiopathy in a Patient with Pancreatic Intraductal Papillary Mucinous Neoplasm.

Authors:  Kyoungkyg Bae; Woon-Jung Kwon; Seong Hoon Choi; Jong Hwa Lee; Hee Jeong Cha
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

3.  Lobar Necrosis from Pulmonary Embolism.

Authors:  Ramiro Fernandez; Jonathan M Tomasko; Daphne Edgren; Ankit Bharat
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

4.  Cavitating lung lesions in chronic thromboembolic pulmonary hypertension.

Authors:  Heather Harris; Richard Barraclough; Christine Davies; Iain Armstrong; David G Kiely; Edwin van Beek
Journal:  J Radiol Case Rep       Date:  2008-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.